The recently-enacted Inflation Reduction Act introduced a 1% excise tax on stock buybacks beginning in 2023, and in the absence of guidance from the Treasury Department, it is unclear whether the tax applies to SPAC share redemptions. More and more SPACs are acting as if it will, and......read more
Three SPACs began trading this past week, joined by one micro-cap, though it was too small to be included in our IPO stats. Two small IPOs submitting initial filings. The biggest news came from the pipeline, as gene editing biotech Prime Medicine (PRME) launched its $151 million IPO. It is expected to list on the Nasdaq in the week ahead. The week’s blank...read more
Hudson Acquisition I, a blank check company targeting technology in the US, raised $60 million by offering 6.0 million units at $10 per unit. Each unit consists of one share of common stock and one right to receive one-fifth of a share upon the completion of an initial business combination. The SPAC is led by Chairman and CEO Jiang Hui, the current...read more
Hudson Acquisition I, a blank check company targeting technology in the US, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share upon the completion of an initial business...read more
A growing list of SPACs plan to liquidate early to avoid a possible 1% excise tax in 2023
The recently-enacted Inflation Reduction Act introduced a 1% excise tax on stock buybacks beginning in 2023, and in the absence of guidance from the Treasury Department, it is unclear whether the tax applies to SPAC share redemptions. More and more SPACs are acting as if it will, and......read more
US IPO Weekly Recap: Quiet October continues with micro-caps and SPACs
Three SPACs began trading this past week, joined by one micro-cap, though it was too small to be included in our IPO stats. Two small IPOs submitting initial filings. The biggest news came from the pipeline, as gene editing biotech Prime Medicine (PRME) launched its $151 million IPO. It is expected to list on the Nasdaq in the week ahead. The week’s blank...read more
SPAC Hudson Acquisition I prices $60 million IPO, targeting US technology
Hudson Acquisition I, a blank check company targeting technology in the US, raised $60 million by offering 6.0 million units at $10 per unit. Each unit consists of one share of common stock and one right to receive one-fifth of a share upon the completion of an initial business combination. The SPAC is led by Chairman and CEO Jiang Hui, the current...read more
Technology-focused SPAC Hudson Acquisition I files for a $60 million IPO
Hudson Acquisition I, a blank check company targeting technology in the US, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million units at $10. Each unit consists of one share of common stock and one right to receive one-eighth of a share upon the completion of an initial business...read more